Table 1.3:
Baseline characteristics between patients who survived or died in the analysis. N refers to number of patients.
| Patient characteristic (N) | Alive (145) | Deceased (62) | P-value |
|---|---|---|---|
| Gender (208) | 0.92 | ||
| Male (109) | 52.4% (76) | 53.2% (33) | |
| Female (99) | 47.6% (69) | 46.8% (29) | |
| Age (208) | 55.1 y ± 11.8 y | 60.3 y ±11.0y | 0.002 |
| WHO grade (204) | 0.026 | ||
| G1 (147) | 71.33% (102) | 73.33% (44) | |
| G2 (50) | 27.27% (39) | 18.33% (11) | |
| G3 (7) | 2.3% (2) | 4% (1) | |
| Nodal involvement (201) | 0.67 | ||
| N0 (21) | 11.5% (16) | 8.2% (5) | |
| N1 (66) | 33.8% (47) | 31.1% (19) | |
| N2 (113) | 54.7% (76) | 60.7% (37) | |
| Mesenteric mass size (191) | 2.41 ± 2.04 cm | 2.83 ± 2.04 cm | 0.175 |
| Octreotide (205) | 0.06 | ||
| Yes (105) | 47.2% (68) | 61.7% (37) | |
| No (100) | 52.8% (76) | 38.3% (23) | |
| Resection status (206) | 0.2 | ||
| R0 (109) | 56.94% (82) | 44.26% (27) | |
| R1 (4) | 1.39% (2) | 3.28% (2) | |
| R2 (93) | 41.67% (60) | 52.46% (32) | |
| Original stage (207) | 0.14 | ||
| I (6) | 2.78% (4) | 3.23% (2) | |
| II (10) | 4.17% (6) | 6.45% (4) | |
| III (95) | 51.39% (74) | 33.87% (21) | |
| IV (96) | 41.67% (60) | 56.45% (35) | |
| T Stage of primary at diagnosis (192) | 0.06 | ||
| T1 (8) | 5.15% (7) | 1.82% (1) | |
| T2 (35) | 13.23% (18) | 29.09% (16) | |
| T3 (96) | 52.21% (71) | 45.45% (25) | |
| T4 (53) | 29.41% (40) | 23.64% (13) | |
| M1 disease at diagnosis (207) | 0.051 | ||
| Yes (96) | 41.7% (60) | 56.5% (35) | |
| No (111) | 58.3% (84) | 43.5% (111) | |
| MTD present (208) | 0.83 | ||
| Yes (138) | 66.2% (96) | 67.7% (42) | |
| No (70) | 33.8% (49) | 32.3% (20) |